Top 10 IM Rabies Vaccine Manufacturers

April 08, 2024

The IM Rabies Vaccine industry is facing a shortage due to increased demand from countries with high incidence of rabies cases. Manufacturers are struggling to meet the demand, leading to price hikes and competition for limited supplies. Governments are working to secure more vaccines to prevent a public health crisis.

Merck
China National Pharmaceutical Group Corporation (Sinopharm)
Novartis
Changchun Zhuoyi Biological Co., Ltd
Sanofi Pasteur
GlaxoSmithKline

Merck

Establishment time : 1668

website : www.merck.com

Main Product : Pharmaceuticals, vaccines, biologics, and animal health products

Company Profile

Merck is a leading pharmaceutical company with a long history of innovation and a commitment to improving human and animal health through its products and research.

China National Pharmaceutical Group Corporation (Sinopharm)

Establishment time : 1998

website : www.sinopharm.com

Main Product : Pharmaceuticals, medical devices, healthcare products

Company Profile

China National Pharmaceutical Group Corporation (Sinopharm) is a state-owned enterprise engaged in the research, development, production, and distribution of pharmaceuticals, medical devices, and healthcare products. With a focus on innovation and quality, Sinopharm has established itself as a leading player in the global healthcare industry.

Novartis

Establishment time : March 1, 1996

website : www.novartis.com

Main Product : Pharmaceuticals, generics, eye care, and more

Company Profile

Novartis is a Swiss multinational pharmaceutical company known for its innovative medicines and commitment to improving global health.

Changchun Zhuoyi Biological Co., Ltd

Establishment time : 2005

website : www1.zhuoyi-bio.com

Main Product : Human Rabies Vaccine,Rabies Prevention ,Freeze-dried Human Rabies Vaccine ,Rabies Vaccine,Human Rabies Vaccination,Human Rabies Vaccine and Infant

Company Profile

Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.

Sanofi Pasteur

Establishment time : Sanofi Pasteur is the vaccines division of the multinational pharmaceutical company Sanofi.

website :

Main Product : Sanofi Pasteur has a long history of vaccine innovation and is a global leader in the field.

Company Profile

Sanofi Pasteur plays a critical role in global efforts to control and eradicate vaccine-preventable diseases.

GlaxoSmithKline

Establishment time : GlaxoSmithKline is a multinational pharmaceutical company

website :

Main Product : The company is headquartered in London, UK

Company Profile

The company is committed to improving the quality of human life through its products and services.

Author:

Mr. Simba Li

E-mail:

lixuejian@zy-bio.cn

Phone/WhatsApp:

+86 18946525326